| Giant Eagle Pharmacy #0081 | |
| 5142 Route 30, Greensburg, Pennsylvania 15601 | |
| (724) 836-7613 |
| Name | Giant Eagle Pharmacy #0081 |
|---|---|
| Organization Name | Giant Eagle Inc |
| Location | 5142 Route 30, Greensburg, Pennsylvania 15601 |
| Type | Community/Retail Pharmacy |
| Phone | (724) 836-7613 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Great Lakes NeuroTechnologies announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson's disease (PD) patients that will better assess motor symptoms in response to new deep brain stimulation (DBS) and pharmaceutical therapies.
Children who suffer from arthritis could one day receive more targeted treatment thanks to potential markers for the severity of the disorder discovered by researchers at the University of Adelaide and Women's and Children's Hospital.
A new brain imaging study has shown that an individual's willingness to work hard to earn money is strongly influenced by the chemistry in three specific areas of the brain. Researchers claim that this could have important implications for the treatment of attention-deficit disorder, depression, schizophrenia and other forms of mental illness characterized by decreased motivation.
Research-clinicians at Children's National Health System led the first study to identify a promising treatment to reduce or prevent brain injury in newborns who have suffered hypoxia-ischemia, a serious complication in which restricted blood flow deprives the brain of oxygen.
› Verified 8 days ago
| NPI Number | 1508807314 |
| Organization Name | GIANT EAGLE, INC |
| Doing Business As | GIANT EAGLE PHARMACY #0081 |
| Type | Community/Retail Pharmacy |
| Address | 5142 Route 30, Suite 140, Greensburg, PA 15601 |
| Phone Number | 724-836-7613 |
News Archive
Great Lakes NeuroTechnologies announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson's disease (PD) patients that will better assess motor symptoms in response to new deep brain stimulation (DBS) and pharmaceutical therapies.
Children who suffer from arthritis could one day receive more targeted treatment thanks to potential markers for the severity of the disorder discovered by researchers at the University of Adelaide and Women's and Children's Hospital.
A new brain imaging study has shown that an individual's willingness to work hard to earn money is strongly influenced by the chemistry in three specific areas of the brain. Researchers claim that this could have important implications for the treatment of attention-deficit disorder, depression, schizophrenia and other forms of mental illness characterized by decreased motivation.
Research-clinicians at Children's National Health System led the first study to identify a promising treatment to reduce or prevent brain injury in newborns who have suffered hypoxia-ischemia, a serious complication in which restricted blood flow deprives the brain of oxygen.
› Verified 8 days ago
News Archive
Great Lakes NeuroTechnologies announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson's disease (PD) patients that will better assess motor symptoms in response to new deep brain stimulation (DBS) and pharmaceutical therapies.
Children who suffer from arthritis could one day receive more targeted treatment thanks to potential markers for the severity of the disorder discovered by researchers at the University of Adelaide and Women's and Children's Hospital.
A new brain imaging study has shown that an individual's willingness to work hard to earn money is strongly influenced by the chemistry in three specific areas of the brain. Researchers claim that this could have important implications for the treatment of attention-deficit disorder, depression, schizophrenia and other forms of mental illness characterized by decreased motivation.
Research-clinicians at Children's National Health System led the first study to identify a promising treatment to reduce or prevent brain injury in newborns who have suffered hypoxia-ischemia, a serious complication in which restricted blood flow deprives the brain of oxygen.
› Verified 8 days ago
Eyecare Greengate Pc Type: Medicare Supplier Location: 6048 Route 30, Greensburg, Pennsylvania 15601 Phone: (724) 836-0802 | |
Giant Eagel Pharmacy #0009 Type: Long Term Care Pharmacy Location: 6204 State Route 30, Greensburg, Pennsylvania 15601 Phone: (724) 836-6756 | |
Giant Eagle Pharmacy #0081 Type: Community/Retail Pharmacy Location: 5142 Route 30, Greensburg, Pennsylvania 15601 Phone: (724) 836-7613 | |
Giant Eagle Pharmacy Ltc #0249 Type: Medicare Supplier Location: 6204 State Route 30, Ste A, Greensburg, Pennsylvania 15601 Phone: (724) 836-6779 | |
Precision Care Pharmac Type: Pharmacy Location: 434 E Pittsburgh St, Greensburg, Pennsylvania 15601 Phone: (724) 834-5113 |